Literature DB >> 24923163

[Whole genome analysis of human group A rotavirus G9p[8] strains in Hebei lulong region, 2009-2011].

Xin Ma, Dan-Di Li, Yan-Qing Guo, Jing-Yao Xiang, Xiu-Ping Li, Zhao-Jun Duan.   

Abstract

Abstract:This study aims to investigate the genetic characteristics of group A rotavirus (GARV) G9P[8] strains from infantile diarrhea samples in Hebei Lulong region from 2009 to 2011. We randomly selected five GARV G9P[8] strains in Hebei Lulong region from 2009 to 2011, amplified the 11 gene fragments of GARVs by RT-PCR, and analyz their full-genome sequences by homology and phylogenetic analysis with DNAStar and MEGA. The nucleotide homology between strains LL11131077 and LL11131083 in 2011 was significantly higher than hat etween them and the other three strains in 2009 and 2010. The G9P[8] GARVs circulating in Hebei Lulong region from 2009 to 2011 elenged to the same genotype as the prevalent G9P[8] GARVs in other parts of the world. However,the two strains in 2011, compared with those in 2009 and 2010, were located in a different sub-branch of the phylogenetic tree and had amino acid mutations at many sites.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24923163

Source DB:  PubMed          Journal:  Bing Du Xue Bao        ISSN: 1000-8721


  2 in total

1.  Active, population-based surveillance for rotavirus gastroenteritis in Chinese children: Beijing Municipality and Gansu Province, China.

Authors:  Jing Zhang; Haixia Liu; Lei Jia; Daniel C Payne; Aron J Hall; Ziqian Xu; Zhiyong Gao; Zhaorui Chang; Baoming Jiang; Umesh D Parashar; Lei Meng; Hongjie Yu; Zhaojun Duan
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

2.  Isolation and characterization of a new candidate human inactivated rotavirus vaccine strain from hospitalized children in Yunnan, China: 2010-2013.

Authors:  Jin-Yuan Wu; Yan Zhou; Guang-Ming Zhang; Guo-Fa Mu; Shan Yi; Na Yin; Yu-Ping Xie; Xiao-Chen Lin; Hong-Jun Li; Mao-Sheng Sun
Journal:  World J Clin Cases       Date:  2018-10-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.